Also, the co-occurrence of NRAS and BRAF, the two most frequently mutated genes in melanoma, is also rarely reported (2.9%), which is in agreement with our observations as we found concomitant NRAS/BRAF variants in 5 (1%) of our melanoma samples (39); however, their clinical impact is not known. This evidence concerns the gene BRAF and melanoma.